Corporate Presentation

Strongly focused on delivering on our strategic objectives for 2024 ZBAL& ZEALAND PHARMA Advance obesity portfolio Ensure regulatory progress for rare disease assets >>>> Initiate first-in- human trials with inflammation assets 52 52

View entire presentation